Cargando…
The novel 19G endobronchial USS (EBUS) needle samples processed as tissue “core biopsies” facilitate PD‐L1 and other biomarker testing in lung cancer specimens: case report and the view point from the Respiratory Physician and the Pathologist
The immunohistochemical expression of Programmed Death Ligand (PD‐L1) predicts responses to PD‐1/PD‐L1 inhibitors in non‐small cell lung cancer (NSCLC). PD‐L1 testing is currently only recommended on tissue specimens; however, in many patients, cytology samples are the only specimens available. The...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591950/ https://www.ncbi.nlm.nih.gov/pubmed/29093818 http://dx.doi.org/10.1002/rcr2.271 |